LNN NYSE Agricultural & Farm Machinery Financials FY2017βFY2026
Lindsay had $636M of revenue in fiscal 2026, down 6.0% on the year before. Over five years, revenue changed +2.3% a year on average.
Hi! I read Lindsayβs latest annual report (fiscal 2026). Here is what stands out:
Good So-so Weak
Are sales growing?
β6.0%
No. Sales fell 6.0% last year.
Does it make a profit?
8.8%
A little. It keeps 8.8% of every sale as profit.
Does profit turn into cash?
5.5%
Partly. 5.5% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
About these figures. Interest coverage for fiscal 2026 is blank: the 10-K's structured data has no interest expense for that year.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Lindsay did it, and the next one. Share prices often move a lot on those days.
Next results
January 7, 2027
Thursday Β· in 74 days
Estimated from the same quarter last year. It will be replaced by the announced date once there is one.
| Date | Results for | Time | Source |
|---|---|---|---|
| Oct 20, 2026 | Q4 '26 | Time not announced | 8-K β |
| Jul 2, 2026 | Q3 '26 | Before the market opens | 8-K β |
| Apr 2, 2026 | Q2 '26 | Before the market opens | 8-K β |
| Jan 8, 2026 | Q1 '26 | Before the market opens | 8-K β |
| Oct 23, 2025 | Q4 '25 | Before the market opens | 8-K β |
| Jun 26, 2025 | Q3 '25 | Before the market opens | 8-K β |
| Apr 3, 2025 | Q2 '25 | Before the market opens | 8-K β |
| Jan 7, 2025 | Q1 '25 | Before the market opens | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Lindsay had $636M of revenue in fiscal 2026, down 6.0% on the year before. Over five years, revenue changed +2.3% a year on average. Its operating margin was 10.5%, down 2.5Β pts: of every 100 in sales, about 11 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
KIRA Β· Lindsay made $55.7M of net profit in fiscal 2026. From fiscal 2017 to 2026, diluted EPS grew 10.5% a year.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was $34.8M in fiscal 2026, 5.5% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
KIRA Β· Lindsay returned $96.1M to shareholders in fiscal 2026, 277% of free cash flow. The diluted share count fell 4.4%.
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Lindsay has $74.8M more cash than debt.
Cash, debt and the ratios that show how comfortably Lindsay can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $117M | $166M | $191M | $251M | $190M |
| Debt incl. finance leases | $116M | $116M | $116M | $115M | $115M |
| Net debt / EBITDA | β0.0x | β0.4x | β0.8x | β1.2x | β0.8x |
| Debt / equity | 0.3x | 0.3x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 22.2x | 27.0x | 23.7x | 48.1x | β |
| Current ratio | 3.0x | 3.6x | 3.9x | 3.7x | 3.2x |
| Quick ratio | 1.8x | 2.4x | 2.7x | 2.8x | 2.3x |
| Total assets | $711M | $746M | $760M | $841M | $815M |
| Total liabilities | $317M | $290M | $279M | $308M | $309M |
| Shareholders' equity | $393M | $456M | $481M | $533M | $506M |
| Net debt (β = net cash) | β$0.6M | β$50.6M | β$75.4M | β$135M | β$74.8M |
KIRA Β· Its return on capital was 11.9%: every 100 invested in the business earned about 12 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
KIRA Β· Lindsay passes 5 of 9 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 7 / 9 | 5 / 9 |
| Accruals ratio | β3.9% | β7.4% | β2.3% |
| Altman Z'' | 8.60 | 8.45 | 8.00 |
What does the share cost, and how does it compare?
KIRA Β· At $105.64 a share, the company is worth $1.1B.
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
In plain words: Move the sliders to try your own guesses about growth. The result is what one share would be worth if those guesses came true. Different guesses give very different answers.
Value per share
β
Adds net cash of $74.8M and divides by 10.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Value per share
β
Reference multiples: today 19.8x Β· peers 32.0x Β· sector 20.6x.
KIRA Β· Lindsay grew sales faster than 3 of its 4 similar companies.
Each companyβs latest fiscal year. Fiscal years end in different months, so periods donβt line up exactly.
In plain words: The same numbers for similar companies, so you can tell whether a figure is high or low for this kind of business.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Lindsay LNN | $1.1B | β6.0% | 10.5% | 5.5% | 11.9% | β | 5 | |
| Toro TTC | $10.1B | β1.6% | 9.1% | 12.8% | 15.9% | 28.1x | 6 | Compare β |
| AGCO AGCO | $7.6B | β13.6% | 5.9% | 7.3% | 10.4% | 14.7x | 8 | Compare β |
| CNH Industrial CNH | $14.3B | β8.8% | β | β | 4.6% | 46.0x | β | Compare β |
| Deere DE | $174.9B | β11.7% | β | 13.4% | β | 35.9x | β | Compare β |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $518M | $548M | $444M | $475M | $568M | $771M | $674M | $607M | $676M | $636M |
| Gross profit | $145M | $152M | $115M | $153M | $150M | $199M | $213M | $191M | $211M | $184M |
| Research and development | $17.1M | $16.0M | $13.9M | $13.9M | $13.4M | $15.1M | $18.2M | $17.1M | $17.9M | $17.0M |
| Operating income | $40.6M | $39.0M | $6.1M | $54.2M | $54.1M | $94.6M | $102M | $76.6M | $88.1M | $66.9M |
| Interest expense | $4.8M | $4.7M | $4.8M | $4.8M | $4.8M | $4.3M | $3.8M | $3.2M | $1.8M | β |
| Pretax income | $35.7M | $33.9M | $2.1M | $48.8M | $50.4M | $87.9M | $100M | $79.0M | $94.6M | $75.3M |
| Income tax | $12.5M | $13.6M | β$0.1M | $10.2M | $7.8M | $22.4M | $28.0M | $12.8M | $20.5M | $19.7M |
| Net income | $23.2M | $20.3M | $2.2M | $38.6M | $42.6M | $65.5M | $72.4M | $66.3M | $74.1M | $55.7M |
| Diluted EPS | $2.17 | $1.88 | $0.20 | $3.56 | $3.88 | $5.94 | $6.54 | $6.01 | $6.78 | $5.33 |
| Diluted shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $39.4M | $33.9M | $3.8M | $46.0M | $44.0M | $3.0M | $120M | $95.8M | $133M | $74.9M |
| Capital expenditure | $8.9M | $11.1M | $23.2M | $21.4M | $26.5M | $15.6M | $18.8M | $29.0M | $42.5M | $40.2M |
| Free cash flow | $30.6M | $22.9M | β$19.4M | $24.6M | $17.5M | β$12.6M | $101M | $66.8M | $90.4M | $34.8M |
| Depreciation and amortization | $16.7M | $16.5M | $14.0M | $19.4M | $19.2M | $20.2M | $19.3M | $21.2M | $20.9M | $23.1M |
| Stock-based compensation | $3.6M | $3.9M | $4.2M | $5.6M | $6.2M | $5.5M | $6.5M | $6.4M | $8.1M | $5.6M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $3.0M | $0.0M | $0.0M | $30.8M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $22.5M | $11.5M | $80.7M |
| Dividends paid | $12.5M | $13.0M | $13.4M | $13.6M | $14.2M | $14.6M | $15.1M | $15.5M | $15.7M | $15.4M |
| Dividends and buybacks | $12.5M | $13.0M | $13.4M | $13.6M | $14.2M | $14.6M | $15.1M | $37.9M | $27.3M | $96.1M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $122M | $161M | $127M | $141M | $147M | $117M | $166M | $191M | $251M | $190M |
| Total debt | $117M | $117M | $117M | $116M | $116M | $116M | $116M | $116M | $115M | $115M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $293M | $331M | $314M | $348M | $416M | $477M | $488M | $493M | $533M | $472M |
| Current liabilities | $92.0M | $80.1M | $82.1M | $102M | $138M | $161M | $136M | $126M | $144M | $150M |
| Inventory | $86.2M | $79.2M | $92.3M | $105M | $145M | $194M | $156M | $155M | $137M | $135M |
| Property and equipment, net | $74.5M | $57.2M | $69.0M | $79.6M | $92.0M | $94.5M | $99.7M | $113M | $142M | $171M |
| Total assets | $506M | $500M | $500M | $571M | $637M | $711M | $746M | $760M | $841M | $815M |
| Total liabilities | $236M | $223M | $232M | $272M | $299M | $317M | $290M | $279M | $308M | $309M |
| Shareholders' equity | $270M | $277M | $268M | $299M | $338M | $393M | $456M | $481M | $533M | $506M |
| Margins | ||||||||||
| Gross margin | 28.0% | 27.7% | 25.8% | 32.1% | 26.5% | 25.8% | 31.6% | 31.5% | 31.2% | 28.9% |
| Operating margin | 7.9% | 7.1% | 1.4% | 11.4% | 9.5% | 12.3% | 15.2% | 12.6% | 13.0% | 10.5% |
| EBITDA margin | 11.1% | 10.1% | 4.5% | 15.5% | 12.9% | 14.9% | 18.0% | 16.1% | 16.1% | 14.2% |
| Net margin | 4.5% | 3.7% | 0.5% | 8.1% | 7.5% | 8.5% | 10.7% | 10.9% | 11.0% | 8.8% |
| FCF margin | 5.9% | 4.2% | β4.4% | 5.2% | 3.1% | β1.6% | 15.0% | 11.0% | 13.4% | 5.5% |
| Returns | ||||||||||
| Return on capital | 9.9% | 9.4% | 2.5% | 16.1% | 15.7% | 20.1% | 18.5% | 15.8% | 17.2% | 11.9% |
| Return on capital employed | 10.0% | 9.4% | 1.5% | 12.2% | 11.2% | 18.1% | 17.6% | 12.3% | 13.2% | 9.8% |
| Return on equity | 8.9% | 7.4% | 0.8% | 13.6% | 13.4% | 17.9% | 17.1% | 14.2% | 14.6% | 10.7% |
| Return on assets | 4.7% | 4.0% | 0.4% | 7.2% | 7.1% | 9.7% | 9.9% | 8.8% | 9.3% | 6.7% |
| Growth | ||||||||||
| Revenue growth | 0.3% | 5.7% | β18.9% | 6.9% | 19.6% | 35.8% | β12.5% | β9.9% | 11.4% | β6.0% |
| Net income growth | 14.4% | β12.5% | β89.3% | 1,678.5% | 10.2% | 53.8% | 10.6% | β8.5% | 11.8% | β24.9% |
| EPS growth | 17.3% | β13.4% | β89.4% | 1,680.0% | 9.0% | 53.1% | 10.1% | β8.1% | 12.8% | β21.4% |
| FCF growth | 41.4% | β25.2% | β184.9% | β | β29.0% | β171.9% | β | β33.8% | 35.4% | β61.6% |
| Share count change | β2.2% | 0.7% | 0.4% | 0.5% | 1.1% | 0.4% | 0.3% | β0.4% | β0.9% | β4.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.1x | β0.8x | β0.5x | β0.3x | β0.4x | β0.0x | β0.4x | β0.8x | β1.2x | β0.8x |
| Debt / equity | 0.4x | 0.4x | 0.4x | 0.4x | 0.3x | 0.3x | 0.3x | 0.2x | 0.2x | 0.2x |
| Interest coverage | 8.6x | 8.3x | 1.3x | 11.4x | 11.4x | 22.2x | 27.0x | 23.7x | 48.1x | β |
| Current ratio | 3.2x | 4.1x | 3.8x | 3.4x | 3.0x | 3.0x | 3.6x | 3.9x | 3.7x | 3.2x |
| Quick ratio | 2.3x | 3.1x | 2.7x | 2.4x | 2.0x | 1.8x | 2.4x | 2.7x | 2.8x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.7% | 2.0% | 5.2% | 4.5% | 4.7% | 2.0% | 2.8% | 4.8% | 6.3% | 6.3% |
| Stock comp / revenue | 0.7% | 0.7% | 0.9% | 1.2% | 1.1% | 0.7% | 1.0% | 1.1% | 1.2% | 0.9% |
| Payouts / FCF | 40.8% | 56.8% | β | 55.5% | 81.2% | β | 14.9% | 56.8% | 30.2% | 276.7% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 6.0 | 3.0 | 7.0 | 5.0 | 5.0 | 6.0 | 6.0 | 7.0 | 5.0 |
| Altman Z'' | 7.4 | 8.3 | 7.4 | 7.5 | 7.3 | 7.8 | 8.4 | 8.6 | 8.5 | 8.0 |
| Accruals ratio | β3.3% | β2.7% | β0.3% | β1.4% | β0.2% | 9.3% | β6.5% | β3.9% | β7.4% | β2.3% |
Source: SEC EDGAR XBRL filings (CIK 0000836157). Data updated October 22, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
